Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1141 |
|---|---|
| Identifier | NCT05121402 |
| Trial Title | Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: TLL018|OTHER: Placebo |
Participant Information
| Sponsor | TLL Pharmaceutical, LLC |
|---|---|
| City | San Antonio |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-12-30 |
|---|---|
| Primary Completion Date | 2023-07-01 |
| Completion Date | 2023-12-30 |